Evidence map›Paper›PMID 30459469›Full record

ArticleEye (London, England)2019

Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio.

Sarah R Dawson, Emma Linton, Kris Beicher, Richard Gale, Praveen Patel, Faruque Ghanchi, Michael W Beresford, Vanessa Poustie, Usha Chakravarthy, Rupert R A Bourne and 1 more

Abstract read
In one paragraph

Article in Eye (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The inverse-research law of eye health.Eye (London, England) · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sarah R DawsonWolverhampton Eye Infirmary, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
Emma LintonManchester Royal Eye Hospital, Manchester, UK.
Kris BeicherNational Institute for Health Research (NIHR CRN), University of Leeds, Leeds, UK.
Richard GaleAcademic Unit of Ophthalmology, York NHS Teaching Hospital, York, UK.
Praveen PatelNIHR Moorfields Biomedical Research Centre, London, UK.ORCID http://orcid.org/0000-0001-8682-4067
Faruque GhanchiBradford Teaching Hospitals, Bradford, UK.ORCID http://orcid.org/0000-0002-4448-8162
Michael W BeresfordInstitute of Translational Medicine, University of Liverpool, Liverpool, UK.
Vanessa PoustieInstitute of Translational Medicine, University of Liverpool, Liverpool, UK.
Usha ChakravarthyQueen's University of Belfast, Belfast, UK.
Rupert R A BourneCambridge University Hospitals, Cambridge, UK. rb@rupertbourne.co.uk.
NIHR Ophthalmology Specialty Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report on the composition and performance of the portfolio of Ophthalmology research studies in the United Kingdom's National Institute for Health Research (NIHR) Clinical Research Network (UK CRN).

methodsOphthalmology studies open to recruitment between 1 April 2010 and 31 March 2018 were classified by: sub-specialty, participant age, gender of Chief Investigator, involvement of genetic investigations, commercial/ non-commercial, interventional/observational design. Frequency distributions for each covariate and temporal variation in recruitment to time and target were analysed.

resultsOver 8 years, 137,377 participants were recruited (average of 15,457 participants/year; range: 5485-32,573) with growth by year in proportion of commercial studies and hospital participation in England (76% in 2017/18). Fourteen percent of studies had a genetic component and most studies (82%) included only adults. The majority of studies (41%) enrolled patients with retinal diseases, followed by glaucoma (17%), anterior segment and cataract (13%), and ocular inflammation (6%). Overall, 68% of non-commercial studies and 55% of commercial studies recruited within the anticipated time set by the study and also recruited to or exceeded the target number of participants.

conclusionsHigh levels of clinical research activity, growth and improved performance have been observed in Ophthalmology in UK over the past 8 years. Some sub-specialties that carry substantial morbidity and a very high burden on NHS services are underrepresented and deserve more patient-centred research. Yet the NIHR and its CRN Ophthalmology National Specialty Group has enabled key steps in achieving the goal of embedding research into every day clinical care.

Indexed as

State MedicineBiomedical ResearchHumansOphthalmologyUnited Kingdom

Identifiers

PMID30459469
PMCPMC6461943

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.